Zealand Pharma A/S (ZEAL) News Today → Crypto Market Preps For Trillions Worth of Inflows! (From Crypto 101 Media) (Ad) Free ZEAL Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineJessie J says she’s the opposite of a ‘beige mum’ as she shows off son’s playroomnz.finance.yahoo.com - March 28 at 1:38 PMNew Zealand Education: International student enrolments top 59,000 for the first eight months of 2023msn.com - March 28 at 1:38 PMOzempic maker Novo Nordisk gets more weight loss drug competition as a rival releases promising datamsn.com - March 28 at 1:38 PMTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated personsglobenewswire.com - March 26 at 5:05 PMZealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrantsglobenewswire.com - March 26 at 5:00 PMZealand Pharma's Annual General Meeting 2024globenewswire.com - March 20 at 12:39 PMTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated personsglobenewswire.com - March 19 at 12:00 PMWeight loss drugs like Ozempic and Wegovy are fattening up Denmark's economy and helped it dodge a recession last yearbusinessinsider.com - March 17 at 8:16 AMWhat is amycretin? The new weight-loss pill that’s ‘twice as effective’ as Ozempicmsn.com - March 15 at 7:53 AMFactbox-Madrigal's drug wins first US approval for fatty liver disease NASH as rivals circleyahoo.com - March 14 at 8:25 PMNew Employee Elected Directors to the Board of Zealand Pharma A/Sglobenewswire.com - March 13 at 5:00 PMWho benefits from direct-to-consumer pharmaceutical advertising?msn.com - March 13 at 1:14 PMTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated personsglobenewswire.com - March 8 at 11:00 AMTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated personsglobenewswire.com - March 5 at 4:05 PMZealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrantsglobenewswire.com - March 5 at 4:00 PMZealand Pharma to Participate in TD Cowen's 44th Annual Health Care Conferenceglobenewswire.com - March 1 at 11:00 AMZealand Pharma A/S (ZEAL.CO)finance.yahoo.com - February 27 at 1:03 PMZealand Pharma Announces Financial Results for the Full Year 2023globenewswire.com - February 27 at 1:00 AMEuropean markets close lower as investors await inflation data; Zealand Pharma up 35%cnbc.com - February 26 at 9:06 PMZealand Pharma stock soars 35% on strong trial results for its weight loss treatmentuk.investing.com - February 26 at 4:06 PMThere might be a weight loss drug competitor to Ozempic — and the company's stock is soaringmsn.com - February 26 at 4:06 PMZealand Pharma’s Survodutide Shows Promise in Obesity Treatment: Latest Trial Results Spark Investor Excitementmsn.com - February 26 at 4:06 PMZealand Pharma announces Boehringer Ingelheim survodutide Phase 2 trial shows 83% of adults treated achieved groundbreaking results in liver disease due to MASH, with significant improvements in fibrosisglobenewswire.com - February 26 at 2:06 AMZealand Pharma A (ZLDPF) Price Target Increased by 5.13% to 66.05msn.com - February 25 at 1:42 AMZealand Pharma conference call on February 27 at 2pm CET (8am ET) to present full year 2023 financial resultsglobenewswire.com - February 20 at 2:00 AMOut of the rabbit hole: new research shows people can change their minds about conspiracy theoriesmsn.com - February 19 at 11:35 PMNew Zealand To Ban 'Forever Chemicals' In Make-upbarrons.com - January 31 at 3:41 PMZealand Pharma A/Sthestreet.com - January 31 at 8:27 AMZealand Pharma major shareholder announcement: Avoro Capital Advisors LLCfinance.yahoo.com - January 10 at 2:57 PMZealand Pharma announces directed issue and private placement for gross proceeds of DKK 1.45 billionfinance.yahoo.com - January 8 at 7:38 PMZealand Pharma to participate in the Goldman Sachs Healthcare C-Suite Unscripted Conference on January 4thfinance.yahoo.com - January 2 at 9:20 AMUS FDA declines to approve Zealand Pharma's drug for low blood sugar in childrenreuters.com - December 23 at 7:26 AMZealand Pharma enters into EUR 90 million finance agreement with the European Investment Bankfinanznachrichten.de - December 22 at 7:09 AMZealand Pharma submits New Drug Application to the US FDA for glepaglutide in short bowel syndromefinance.yahoo.com - December 22 at 7:09 AMZealand Pharma A (ZLDPF) Price Target Increased by 10.04% to 57.56msn.com - December 16 at 11:42 AMZealand Pharma appoints Enrique Conterno and Elaine Sullivan as board observersfinance.yahoo.com - November 30 at 4:26 AMZealand Pharma reports 9M resultsmsn.com - November 9 at 10:40 AMZealand Pharma to participate in the Jefferies London Healthcare Conference in November 2023finance.yahoo.com - November 7 at 6:42 AMAdvanz Pharma to license Dimerix’s DMX-200 drug candidatemsn.com - October 5 at 2:37 PMZealand Pharma A (ZLDPF) Price Target Increased by 19.27% to 51.70msn.com - October 5 at 9:37 AMFDA grants priority review for Zealand Pharma’s dasiglucagonmsn.com - August 30 at 9:25 AMZealand Pharma announces designation of priority review by the US FDA for dasiglucagon in congenital hyperinsulinismfinance.yahoo.com - August 30 at 4:25 AMShould New Zealand become a state of Australia? Debate erupts after shock proposal: 'An idea worth considering'msn.com - August 24 at 4:31 AMBoehringer Ingelheim advances obesity drug candidate with up to 19% weight loss in mid-stage trialfoxnews.com - August 18 at 3:51 AMZealand Pharma announces positive results from Part 1 of multiple ascending dose trial with amylin analog ZP8396finance.yahoo.com - July 3 at 8:16 AMZealand Pharma Submits Marketing Authorization Application To EMA For Dasiglucagonmarkets.businessinsider.com - June 26 at 10:13 AMData shows nearly 19% weight loss in people with overweight or obesity in Boehringer Ingelheim and Zealand Pharma Phase II trial with survodutide (BI 456906) 1businesswire.com - June 23 at 10:29 PMNasdaq Copenhagen A/S: Zealand Pharma A/S - admittance to trading and official listing of new shares due to exercise of employee warrantsfinanznachrichten.de - June 12 at 11:50 AMSun Pharma, Philogen sign agreement for commercialising Nidlegy in Europe, Australia and New Zealandmsn.com - May 30 at 4:51 PMZealand Pharma A/S (ZLDPF) Is a Great Choice for 'Trend' Investors, Here's Whymsn.com - May 18 at 1:33 PM Get Zealand Pharma A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for ZEAL and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now ZEAL Media Mentions By Week ZEAL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZEAL News Sentiment▼1.080.61▲Average Medical News Sentiment ZEAL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZEAL Articles This Week▼51▲ZEAL Articles Average Week Get Zealand Pharma A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for ZEAL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Praxis Precision Medicines News Today Evolus News Today Tango Therapeutics News Today PureTech Health News Today Tyra Biosciences News Today Pliant Therapeutics News Today Cassava Sciences News Today Arcturus Therapeutics News Today MacroGenics News Today Astria Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZEAL) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI healthcare stock poised for 36,996% growth?Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zealand Pharma A/S Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.